Aprepitant Oral Suspension and Secukinumab Subcutaneous
Determining the interaction of Aprepitant Oral Suspension and Secukinumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: secukinumab
Brand name: Cosentyx, Cosentyx Sensoready Pen
Synonyms: Secukinumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant Oral Suspension-Secura Antifungal
- Aprepitant Oral Suspension-Secura Antifungal Extra Thick
- Aprepitant Oral Suspension-Secura Antifungal Topical
- Aprepitant Oral Suspension-Seebri
- Aprepitant Oral Suspension-Seebri Neohaler
- Aprepitant Oral Suspension-Seebri Neohaler inhalation
- Secukinumab Subcutaneous-Aprepitant/Fosaprepitant Dimeglumine
- Secukinumab Subcutaneous-Apresazide
- Secukinumab Subcutaneous-Apresoline
- Secukinumab Subcutaneous-Apresoline Injection
- Secukinumab Subcutaneous-Apri
- Secukinumab Subcutaneous-Apriso